Procedures & recovery · patient guide

How is dementia assessed in China?

A dementia assessment in China follows the same clinical logic used internationally: a history taken from the patient and someone who knows them well, cognitive and functional testing, a medication and general-health review, blood tests to exclude reversible causes, and brain imaging where indicated. Neurologists, geriatricians or memory-clinic teams decide which steps an individual needs. No single test confirms dementia, and an overseas patient should confirm the intended assessment pathway with the receiving hospital before travelling.

Go to the practical guidance ↓
AI illustration: A doctor in a white coat consulting with an elderly couple in a comfortable office setting with a table and plants.
AI-generated illustration for care planning; not a photograph of a real patient, clinician or hospital, and not a diagnostic image.
In this guide

What a dementia assessment actually consists of

Dementia is a syndrome, not a single disease, and no blood test or scan diagnoses it on its own. A clinician builds the picture from several sources. The first is the history: when memory or language or behaviour changes began, how quickly they progressed, what daily tasks are now difficult, and whether there have been sudden worsening episodes, falls, hallucinations or personality change. Because a person with cognitive impairment may under-report difficulties, clinicians place weight on an account from a family member, partner or carer who sees them regularly.

The second element is structured cognitive testing. This ranges from short screening instruments such as the Mini-Mental State Examination or Montreal Cognitive Assessment to longer neuropsychological batteries that examine memory, attention, language, visuospatial skills and executive function in detail. A short screen can suggest impairment but does not by itself separate dementia from delirium, depression, hearing loss or low education. Formal neuropsychological testing is more informative when the diagnosis is unclear or when the pattern matters for distinguishing between conditions.

The third element is a general medical review. Clinicians look for conditions that can mimic or worsen cognitive decline, including thyroid disease, vitamin deficiencies, infections, sleep problems, hearing and vision loss, and the effects of medicines. Blood tests are commonly used to check for some of these. Brain imaging, usually CT or MRI, is used to look for stroke, bleeding, tumours, hydrocephalus or patterns of atrophy, and is interpreted alongside the clinical picture rather than in isolation. Which of these steps an individual needs is a clinical decision, and a patient should ask the receiving team which tests their assessment will include.

Who you would see, and why the route matters

In China, cognitive concerns are assessed within neurology, geriatrics or psychiatry depending on the hospital and the patient's age and presentation, and some larger hospitals run dedicated memory or cognitive-disorder clinics. The right entry point depends on the question being asked. A person with prominent memory loss and no other neurological signs may be seen first by a neurologist or geriatrician; someone with marked behavioural or mood change may be directed to psychiatry. A patient with a known genetic or rare cause may need a specialist centre.

For an international patient, the practical question is not only which specialty but which hospital can deliver the whole assessment in a coordinated way. Cognitive testing, imaging and specialist review may sit in different departments, and the sequence of appointments affects how long a visit takes. Rather than assuming a single visit covers everything, ask the hospital how the assessment is organised, whether the cognitive testing is done by a neuropsychologist or by the consulting doctor, and whether the results are discussed with the patient and family in one review or across several appointments.

Language is a substantive issue in cognitive testing, not only a comfort issue. Many cognitive instruments were developed and validated in particular languages and educational settings, and scores can be affected by translation, literacy and cultural familiarity with test items. Ask whether the hospital can administer testing in the patient's language or with a validated version, and whether an interpreter would be present during testing itself. Interpretation of results by a clinician experienced with the patient's background matters as much as the test chosen.

Neurosurgery and neuroscience care in China

Records that make the assessment more useful

A dementia assessment depends heavily on comparison over time, so records that show change are valuable. Bring any previous cognitive test scores with dates, prior brain imaging and its reports, and a list of current medicines including doses and who prescribed them. If there have been hospital admissions, falls, or episodes of confusion, brief dated notes help the clinician reconstruct the timeline. A short written summary from the family of what has changed and when is often more useful than a long narrative.

It also helps to be clear about what the patient and family want from the assessment. Are they seeking a diagnosis, a second opinion on a diagnosis already given, advice on medicines, or planning for care and safety? These lead to different conversations. If a diagnosis has already been made elsewhere, bring the report and the basis for it, including which tests were done. If no diagnosis has been made, say so plainly rather than presenting a working label as established.

One boundary is worth stating early: a records-based review before travel can discuss the likely questions and what tests may be relevant, but it cannot replace examination and formal testing. The treating hospital decides what assessment is appropriate once it has seen the patient. A remote opinion is a planning tool, not a diagnosis.

Ruling out reversible and overlapping conditions

A central part of any good assessment is checking whether something treatable is contributing. Delirium, an acute confusional state often triggered by infection, medicines, pain or surgery, can look like dementia and needs urgent medical attention rather than a routine outpatient workup. Depression in older adults can produce marked cognitive slowing and memory complaints. Untreated hearing loss, sleep apnoea, thyroid disease and vitamin B12 deficiency are among the conditions clinicians consider. This is why the assessment is not simply a memory test followed by a scan.

Medication review deserves particular attention. Anticholinergic drugs, sedatives, some pain medicines and combinations of treatments can impair cognition, and a clinician may adjust them after review. Patients should not stop or change prescribed medicines themselves before the assessment; instead, bring a complete list and let the treating doctor decide. Similarly, if the patient is already taking a medicine for dementia, the assessment should establish what it is, why it was started and how it is being monitored, because this affects what the new team recommends.

Some patients arrive hoping for a specific test they have read about. It is reasonable to ask whether a particular investigation is available and appropriate, but the answer depends on the clinical question. A clinician may explain that a test adds little without other findings, or that it is used only in selected situations. The useful question is not 'can I have this test' but 'what would this test change in my case, and what are its limitations'.

What a diagnosis does and does not settle

When a diagnosis of dementia is made, it usually names a syndrome and, where possible, a likely cause such as Alzheimer's disease, vascular cognitive impairment, Lewy body disease or frontotemporal dementia. Certainty varies. Some diagnoses rest on a characteristic clinical pattern plus supportive imaging; others remain probabilistic and are reviewed as things change. A clinician may use terms such as 'probable' or 'possible' deliberately, and patients should feel able to ask what level of certainty applies and what would prompt a review.

A diagnosis is also the starting point for a plan rather than the end of the process. That plan may include treatment options, safety at home, driving, financial and legal arrangements, support for the carer, and follow-up. For an overseas patient, an important practical question is what can realistically be arranged in China and what should continue at home. Follow-up testing, medication monitoring and carer support usually need a local team, so ask the hospital what it will hand back in writing and to whom.

Families sometimes travel expecting a definitive answer within a short visit. It is fair to ask the hospital in advance what it can and cannot conclude from the assessment it plans, and whether any results will need to be reviewed after the patient has returned home. That conversation sets realistic expectations without prejudging the clinical outcome.

Practical preparation and the next step

Before travelling, confirm with the specific hospital which appointments are booked, who will conduct the cognitive testing, what language arrangements exist, and which records they want in advance. Ask whether the assessment is expected to require more than one visit and whether results are given in writing in English. These are questions about that hospital's arrangements, not facts that can be assumed across China, so get the answers in writing where possible.

Bring the patient's medicine list, prior test scores, imaging reports and a dated summary of changes, and travel with someone who knows the patient well, since the informant history is part of the assessment. If the patient has sudden confusion, fever, a fall with head injury or rapid deterioration, seek urgent local medical care rather than waiting for a scheduled appointment.

ChinaSpecialistCare can help an international patient plan this kind of assessment by reviewing a brief summary, identifying what records are missing and suggesting a relevant next step, and by coordinating specialist appointments at public tertiary or private international hospitals. An initial enquiry is free and does not commit you to a proxy consultation; the receiving hospital decides what assessment is suitable. Start with a short summary of the concern and the main question you want answered.

Sources & scope of this guide

References and official service information relevant to this guide.

  1. Neurosurgery and neuroscience care in China
  2. NICE guideline NG97: Dementia - assessment, management and support for people living with dementia and their carers
  3. WHO: Dementia fact sheet

This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.